A Single-Center, Randomized, Open-Label, Crossover Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects
Latest Information Update: 02 Jul 2025
At a glance
- Drugs HRS-5965 (Primary)
- Indications Glomerulonephritis; IgA nephropathy; Paroxysmal nocturnal haemoglobinuria
- Focus Pharmacokinetics
- Sponsors Chengdu Suncadia Medicine
Most Recent Events
- 02 Jul 2025 New trial record